Begmiron-S 50 Tablet ER
Marketer
Fawn Incorporation
Salt Composition
Mirabegron (50mg) + Solifenacin (5mg)
Overview Begmiron-S 50 Tablet ER
Combiflex-50 Extended Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication offers relief from frequent urination, urgency, and incontinence. Always adhere to your physician's prescribed dosage and schedule for Combiflex-50 ER; it can be taken with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms, so complete the full course as directed. Commonly reported side effects include elevated blood pressure, upper respiratory tract inflammation, urinary infections, and headaches. Report any persistent or bothersome side effects to your doctor immediately. Prior to starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Individuals with liver or kidney impairment should exercise caution, requiring regular monitoring by their healthcare provider.
Primary Ingredients of Begmiron-S 50 Tablet ER
No text provided to rephrase.
Uses of Begmiron-S 50 Tablet ER
Symptoms indicative of an overactive bladder
Major Benefits of Begmiron-S 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Begmiron-S 50 Tablet ER can be administered with or without food, although consistent timing is recommended.
Common Side effects of Begmiron-S 50 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Begmiron-S 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Begmiron-S 50 Tablet ER can be administered with or without food, though consistent timing is recommended.
How Begmiron-S 50 Tablet ER works:
Begmiron-S 50 Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through a different mechanism, also relaxing bladder musculature. This dual action reduces urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Begmiron-S 50 Tablet ER and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Data on Begmiron-S 50 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Begmiron-S 50 Tablet ER with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Begmiron-S 50 Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Begmiron-S 50 Tablet ER's application in individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Begmiron-S 50 Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Begmiron-S 50 Tablet ER :
NA
Facts to Know About Begmiron-S 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urology |



